Reduction in transforming growth factor-β type II receptor in mouse lung carcinogenesis
- 1 May 1998
- journal article
- Published by Wiley in Molecular Carcinogenesis
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Loss of functional cell surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemiaProceedings of the National Academy of Sciences, 1997
- Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibitionInternational Journal of Cancer, 1996
- Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma CellsJournal of Biological Chemistry, 1995
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- The TGF-β family and its composite receptorsTrends in Cell Biology, 1994
- Multimodality Therapy for Stage IIIA (N2) Lung CancerChest, 1993
- Transforming Growth Factor‐βAnnals of the New York Academy of Sciences, 1990
- Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.Proceedings of the National Academy of Sciences, 1989
- The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptorsCell, 1987
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979